An SMU professor and his students are collaborating with Vermont's Applied Research Associates to develop "microrobots" to ...
SMU nanotechnology expert MinJun Kim is working with Applied Research Associates, Inc. to develop microrobots that could ...
ARA and its partners are leveraging microrobotics for numerous applications including targeted drug delivery, minimally ...
MedPage Today on MSN5d
FDA Approves Ocular Implant for Vision-Threatening MacTelThe FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia ...
Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced that the U.S. Food and Drug Administration (FDA), has ...
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...
The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).
ENCELTO is the First and Only FDA-approved Treatment for MacTel. CUMBERLAND, RI, USA I March 06, 2025 I Neurotech Pharmaceuticals, Inc., a private biotech company focused on d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback